20273 results for «»
20273 results
PCR Planet: interventional cardiology in the context of COVID-19 in France and Germany
25 May 2020
N. Karam, France, and F. Mahfoud, Germany, discuss the challenges of practising cardiology in the context of the COVID-19 pandemic with W. Wijns.

PCR Planet: interventional cardiology in the context of COVID-19 in South Africa and Egypt
19 May 2020
H Khamis, Egypt, and M Ntsekhe, South Africa, discuss the challenges of practising cardiology in the context of the COVID-19 pandemic with W Wijns.

Ten-year outcomes after DES versus CABG for LM coronary disease: extended follow-up of the PRECOMBAT trial
27 Apr 2020
This 10-year follow-up of the randomised PRECOMBAT trial adds to the already published long-term randomised comparisons of PCI vs. CABG for LM disease, including the data from SYNTAX (10 years), EXCEL (5 years) and NOBLE (5 years) trials.

Reviewer

Marta Sitges
Barcelona, Spain

Revascularisation strategies - PCR e-Course 2020 Hot lines
29 Jul 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.

CT guidance for coronary interventions - PCR e-Course 2020 Hot lines
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.

PCR e-Course 2020 Late-Breaking Trials - part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- 2-year safety of revascularisation deferral based on iFR or FFR
- CABG and PCI in patients with CTO and multivessel disease
- Routine revascularisation vs. medical therapy

PCR e-Course Hot Lines in STEMI interventions: First-in-Man and novel pharmacological strategies
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines in STEMI interventions presented during PCR e-Course 2020, followed by an analysis of these results and their impact on your practice: MOCA I Study, ON-TIME 3 trial, FABOLUS FASTER.

PCR e-Course Hot lines: drugs and devices for STEMI management
Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.

Physiology or intracoronary imaging; or both? or none? - part 1
27 Jun 2020 – From PCR e-Course 2020
Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.

PCR e-Course 2020 Hot line: left atrial appendage closure
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on LAA closure presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: LAA occlusion vs. NOAC, Amulet IDE Roll-in cohort, identification of potential LAAC candidates.

Crossover results from the RADIANCE-HTN SOLO trial
26 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to learn about latest results from RADIANCE-HTN SOLO cohort and to review blood pressure results following crossover to ultrasound RDN in patients originally randomised to the sham arm in RADIANCE-HTN SOLO.
Videos included on this page: the Hot Line presentation, an...

Physiology or intracoronary imaging; or both? or none? - part 2
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SOCT-PCI Study, impact of PPG index on PCI, angiography-derived IMR.

Microcatheter-based coronary physiology in the diagnosis of coronary stenosis: where and how?
Watch this video to discuss how to spare resources using physiology tools as work-horse PCI devices and to learn how to safely & accurately optimize stent implantation by post-PCI microcatheter-based invasive physiology.
Speakers: Emanuele Barbato, Salvatore Brugaletta, Carlos Collet
This interview supported by Insight Lifetech was filmed at PCR...

The new paradigm for coronary interventions
Watch this session to understand indications for DEB vs. DES & the potential advantage of a sustained sirolimus release when utilised in a DEB, and to get insights into the breakthrough technology of SELUTION SLR & its initial clinical data & clinical experience.
Speakers: Stephan Windecker, Robert...

Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?
25 Jun 2020 – From PCR e-Course 2020
Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.
Videos included on this page: the abstract presentation and an Investigator Perspective.

Hot line on PCI: high bleeding risk and DAPT - part 2
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: TWILIGHT CHINA, SMART-CHOICE, LEADERS FREE III.

Dynamic coronary roadmap for contrast reduction (DCR4Contrast) trial
Watch this Investigator Interview to learn more on contract reduction, why contrast usage is important and why we need it in clinical practice.
Speaker: Javier Escaned
This interview supported by Philips was filmed at PCR e-Course 2020 : see more videos here…

Shockwave IVL Safety and Performance in Eccentric Calcified Coronary Lesions
Watch this Investigator Interview if you want to understand the challenges of treating eccentric calcium, to learn about the initial IVL clinical experience in eccentric calcium and to realise best practices when treating eccentric calcium with IVL
Speaker: Holger Nef
This interview supported by Shockwave Medical was filmed at...

Subcutaneous selatogrel inhibits platelet aggregation in patients with acute myocardial infarction
07 Jul 2020
This study sought to assess the antiplatelet response to selatogrel, a novel subcutaneous reversible P2Y12 receptor antagonist, in patients with AMI.

Reviewer

Reviewer
